Elevated admission glucose is associated with increased long-term mortality in myocardial infarction patients, irrespective of the initially applied reperfusion strategy
Authors:
- Jan-Hein CornelJCJan-Hein Cornel
- Tjeerd van der PloegTPTjeerd van der Ploeg
- Eric BoersmaEBEric Boersma
- Victor A. UmansVUVictor A. Umans
- 1 September 2010
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 160 (3) , 412-419
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Tight Glycemic Control Reduces Heart Inflammation and Remodeling During Acute Myocardial Infarction in Hyperglycemic PatientsJACC, 2009
- Percutaneous Coronary Intervention With Off-Site Cardiac Surgery Backup for Acute Myocardial Infarction as a Strategy to Reduce Door-to-Balloon TimeThe American Journal of Cardiology, 2007
- Effect of Hyperglycemia and Insulin in Acute Coronary SyndromesThe American Journal of Cardiology, 2007
- Admission Blood Glucose Level as Risk Indicator of Death After Myocardial Infarction in Patients With and Without Diabetes MellitusArchives of internal medicine (1960), 2004
- Impaired glucose metabolism predicts mortality after a myocardial infarctionInternational Journal of Cardiology, 2001
- Long-Term Benefit of Primary Angioplasty as Compared with Thrombolytic Therapy for Acute Myocardial InfarctionNew England Journal of Medicine, 1999
- Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients.Diabetes Care, 1999
- Expected infarct size without thrombolysis', a concept that predicts immediate and long-term benefit from thrombolysis for evolving myocardial infarctionEuropean Heart Journal, 1997
- Tailored thrombolytic therapy. A perspective.Circulation, 1993
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993